S03518 - Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.
New York - 2023-2024 General Assembly
Introduced byNathalia Fernandez, Joseph P. Addabbo
Last updated 9 months ago
2 Co-Sponsors
STATUS
Engrossed
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity nowError
You must be a resident or registered voter in this state.